Anti-Mllerian hormone as a predictor of follicular reserve in ovarian insufficiency: Special emphasis on FSH-resistant ovaries

Human Reproduction

Volumn 27, Issue 3, 2012, Pages 854-860

  Kallio, S ^a   Aittomki, K ^b   Piltonen, T ^a   Veijola, R ^c   Liakka, A ^a   Vaskivuo, T E ^a   Dunkel, L ^d,e   Tapanainen, J S ^a,f  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

AMH; FSH receptor mutation; ovarian insufficiency; ovarian reserve; turner syndrome

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; MOSAICISM; OVARIAN RESERVE; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY INSUFFICIENCY; PATIENT IDENTIFICATION; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIMARY AMENORRHEA; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE SECTION; AMENORRHEA; BLOOD; DRUG EFFECT; METABOLISM; OVARY FOLLICLE; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SEX CHROMOSOME ABERRATION; TURNER SYNDROME; X CHROMOSOME;

ADOLESCENT; ADULT; AMENORRHEA; ANTI-MULLERIAN HORMONE; CHILD; CHROMOSOMES, HUMAN, X; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MOSAICISM; OVARIAN FOLLICLE; SEX CHROMOSOME ABERRATIONS; TURNER SYNDROME;

EID: 84857219230     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der473     Document Type: Article

References (42)

1. Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehväslaiho H, Engel AR et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-968.
2. Aittomäki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996;81:3722-3726. (Pubitemid 26339945)
3. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, Grootegoed JA. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995;136:4951-4962.
4. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18:2368-2374. (Pubitemid 37427819)
5. Borgström B, Hreinsson J, Rasmussen C, Sheikhi M, Fried G, Keros V, Fridström M, Hovatta O. Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab 2009;94:74-80.
6. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O. Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 2006;21:2223-2227. (Pubitemid 44530593)
7. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362. (Pubitemid 34083560)
8. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999;140:5789-5796. (Pubitemid 30645368)
9. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-1084. (Pubitemid 34164056)
10. Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323-327. (Pubitemid 36236265)
11. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657-687. (Pubitemid 40090006)
12. Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010;95:5003-5010.
13. Hovatta O. Pregnancies in women with Turner's syndrome. Ann Med 1999;31:106-110. (Pubitemid 29209865)
14. Hreinsson JG, Otala M, Fridström M, Borgström B, Rasmussen C, Lundqvist M, Tuuri T, Simberg N, Mikkola M, Dunkel L et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab 2002;87:3618-3623. (Pubitemid 34879504)
15. Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born BM, de Jong FH, Groome NP, Themmen AP, Visser JA. Serum anti-müllerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006;147:3228-3234. (Pubitemid 43901114)
16. Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, Beerendonk CC, Laven JS, Goverde AJ, Broekmans FJ, Themmen AP et al. Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009; 94:786-792.
17. Kuiri-Hänninen T, Kallio S, Seuri R, Tyrvainen E, Liakka A, Tapanainen J, Sankilampi U, Dunkel L. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J Clin Endocrinol Metab 2011;96:3432-3439.
18. La Marca A, Pati M, Orvieto R, Stabile G, Carducci Artenisio A, Volpe A. Serum anti-müllerian hormone levels in women with secondary amenorrhea. Fertil Steril 2006;85:1547-1549.
19. La Marca A, Marzotti S, Brozzetti A, Stabile G, Artenisio AC, Bini V, Giordano R, De Bellis A, Volpe A, Falorni A et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J Clin Endocrinol Metab 2009; 94:3816-3823.
20. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-576. (Pubitemid 26055665)
21. Meduri G, Massin N, Guibourdenche J, Bachelot A, Fiori O, Kuttenn F, Misrahi M, Touraine P. Serum anti-Müllerian hormone expression in women with premature ovarian failure. Hum Reprod 2007;22:117-123. (Pubitemid 44942674)
22. Modi D, Bhartiya D, Puri C. Developmental expression and cellular distribution of Müllerian inhibiting substance in the primate ovary. Reproduction 2006;132:443-453. (Pubitemid 44524508)
23. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606-614.
24. Persani L, Rossetti R, Cacciatore C, BonomiM. Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009;33:35-41.
25. Piltonen T, Koivunen R, Ruokonen A, Tapanainen JS. Ovarian age-related responsiveness to human chorionic gonadotropin. J Clin Endocrinol Metab 2003;88:3327-3332. (Pubitemid 36877512)
26. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005;20:1820-1826. (Pubitemid 40932362)
27. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:1973-1978.
28. Rajpert-De Meyts E, Jørgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999;84:3836-3844. (Pubitemid 30645250)
29. Rebar RW. Premature ovarian failure. Obstet Gynecol 2009; 113:1355-1363.
30. Reynaud K, Cortvrindt R, Verlinde F, De Schepper J, Bourgain C, Smitz J. Number of ovarian follicles in human fetuses with the 45, X karyotype. Fertil Steril 2004;81:1112-1119. (Pubitemid 38452982)
31. Schmidt KL, Kryger-Baggesen N, Byskov AG, Andersen CY. Anti-Müllerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol 2005;234:87-93.
32. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468-471. (Pubitemid 34177199)
33. Siljander HT, Simell S, Hekkala A, Lähde J, Simell T, Vähäsalo P, Veijola R, Ilonen J, Simell O, Knip M. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009;58:2835-2842.
34. Singh RP, Carr DH. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966;155:369-383.
35. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S, Randolph JF Jr. Anti-müllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
36. Speed RM. Oocyte development in XO foetuses of man and mouse: the possible role of heterologous X-chromosome pairing in germ cell survival. Chromosoma 1986;94:115-124.
37. Stubbs SA, Hardy K, Da Silva-Buttkus P, Stark J, Webber LJ, Flanagan AM, Themmen AP, Visser JA, Groome NP, Franks S. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab 2005;90:5536-5543. (Pubitemid 41415455)
38. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004; 351:1227-1238.
39. Tran D, Picard JY, Campargue J, Josso N. Immunocytochemical detection of anti-müllerian hormone in Sertoli cells of various mammalian species including human. J Histochem Cytochem 1987;35:733-743. (Pubitemid 17121595)
40. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, de Jong FH, Themmen AP, Hakvoort-Cammel FG, van den Bos C, van den Berg H et al. Anti-Müllerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007;92:3869-3874. (Pubitemid 47607635)
41. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071. (Pubitemid 35469254)
42. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83. (Pubitemid 38196508)